The effect of oral prostaglandin analogue on painful diabetic neuropathy: A double-blind, randomized, controlled trial

Diabetes, Obesity and Metabolism

Volumn 15, Issue 2, 2013, Pages 185-188

  Shin, S ^a   Kim, K J ^b,c   Chang, H J ^a   Lee, B W ^b   Yang, W I ^a   Cha, B S ^b   Choi, D ^a  

^a Yonsei University Health System   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Beraprost; Endothelial dysfunction; Painful diabetic neuropathy

Indexed keywords

BERAPROST; PLACEBO;

ADULT; ANALGESIA; ARTICLE; BURN; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NADIR TO PEAK; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PARESTHESIA; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; TEMPERATURE REBOUND; TOTAL SYMPTOM SCORE; TREATMENT DURATION;

EID: 84871937278     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12010     Document Type: Article

References (12)

1. Ziegler D. Treatment of diabetic neuropathy and neuropathic pain. Diabetes Care 2008; 31: S255.
2. Yuen KC, Baker NR, Rayman G. Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray: a double-blind placebo-controlled cross-over study. Diabetes Care 2002; 25: 1699-1703.
3. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1996; 27: 567-574.
4. Calles-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 2001; 22: 36-52.
5. Niwano K, Arai M, Koitabashi N et al. Competitive binding of CREB and ATF2 to cAMP/ATF responsive element regulates eNOS gene expression in endothelial cells. Arterioscler Thromb Vasc Biol 2006; 26: 1036-1042.
6. Aso Y, Tayama K, Takanashi K, Inukai T, Takemura Y. Changes in skin blood flow in type 2 diabetes induced by prostacyclin: association with ankle brachial index and plasma thrombomodulin levels. Metabolism 2001; 50: 568-572.
7. Ziegler D, Hanefeld M, Ruhnau KJ et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 1999; 22: 1296.
8. Jeong I-K, King GL. New perspectives on diabetic vascular complications: the loss of endogenous protective factors induced by hyperglycemia. Diabetes Metab J 2011; 35: 8-11.
9. Agrawal RP, Goswami J, Jain S, Kochar DK. Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: a prospective double-blind randomized placebo-controlled study. Diabetes Res Clin Pract 2009; 83: 371-378.
10. Agrawal RP, Choudhary R, Sharma P et al. Glyceryl trinitrate spray in the management of painful diabetic neuropathy: a randomized double blind placebo controlled cross-over study. Diabetes Res Clin Pract 2007; 77: 161-167.
11. Rayman G, Baker NR, Krishnan ST. Glyceryl trinitrate patches as an alternative to isosorbide dinitrate spray in the treatment of chronic painful diabetic neuropathy. Diabetes Care 2003; 26: 2697-2698.
12. Kim CH. Endothelial dysfunction-its molecular mechanism and potential implication in therapy. Korean Circulation J 2006; 36: 609-611.